Bellevue Group’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bellevue Group’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-203,329	Closed	-$28.5M	–	233
2020 Q3	$28.5M	Sell	203,329 -53,929	-21%	-$6.57M	0.39%	70
2020 Q2	$19.3M	Sell	257,258 -13,974	-5%	-$731K	0.27%	81
2020 Q1	$7.74M	Buy	271,232 +88,658	+49%	+$2.3M	0.15%	98
2019 Q4	$4.58M	Buy	182,574 +139,354	+322%	+$3.33M	0.07%	114
2019 Q3	$754K	Buy	+43,220	New	+$1.31M	0.01%	150

Bellevue Group's LVGO Position: Q4 2020 in Review

Bellevue Group sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 203,329 shares — an estimated $28.5M sold.

Bellevue Group first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $28.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Bellevue Group reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Bellevue Group sold 203,329 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $28.5M.
Bellevue Group first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Bellevue Group's Livongo Health, Inc. Common Stock position peaked at $28.5M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Bellevue Group's 13F filing for Q4 2020, filed 16 Feb 2021.